Infect Chemother.  2024 Sep;56(3):308-328. 10.3947/ic.2024.0038.

Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections

Affiliations
  • 1Division of Infectious Diseases, Department of Internal Medicine, Hanyang University Seoul Hospital, Seoul, Korea
  • 2Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea
  • 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
  • 4Division of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
  • 5Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
  • 6Department of Infectious Diseases, Yonsei University Yongin Severance Hospital, Yongin, Korea
  • 7Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
  • 8Department of Laboratory Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea

Abstract

This guideline aims to promote the prudent use of antibacterial agents for managing carbapenem-resistant Enterobacterales (CRE) infections in clinical practice in Korea. The general section encompasses recommendations for the management of common CRE infections and diagnostics, whereas each specific section is structured with key questions that are focused on antibacterial agents and disease-specific approaches. This guideline covers both currently available and upcoming antibacterial agents in Korea.

Keyword

Carbapenem-resistant Enterobacterales; Antibacterial agents; Practice guideline
Full Text Links
  • IC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr